Nanomedicine for immunotherapy

Immunotherapy aims to help patients’ immune system to fight cancer. T cells play a very important role in immune responses to cancer. Drugs such as mRNA can be employed to target T cells to elicit strong immune responses. The project to be carried out in the Institute for Bioengineering at the University of Edinburgh is going to develop nanomedicines to facilitate localized mRNA delivery to target T cells in tumor tissues for improved immunotherapy.

To undertake this research, we are seeking a highly motivated candidate with established hands-on experience in nanomaterials, chemistry or cancer biology.

Further Information:

The University of Edinburgh is committed to equality of opportunity for all its staff and students, and promotes a culture of inclusivity. Please see details here:

Closing Date: 

Friday, March 10, 2023

Principal Supervisor: 


Minimum entry qualification - an Honours degree at 2:1 or above (or International equivalent) in chemical engineering, chemistry, materials science, biomedical engineering, or cell biology, possibly supported by an MSc Degree.

English language requirements need to be satisfied by EU/Overseas applicants. Further information on English language requirements for EU/Overseas applicants.


Applications are welcomed from self-funded students, or students who are applying for scholarships from the University of Edinburgh or elsewhere.

Further information and other funding options.

Informal Enquiries: